Functional activity of antibodies against the recombinant OpaJ protein from Neisseria meningitidis
- PMID: 12704102
- PMCID: PMC153225
- DOI: 10.1128/IAI.71.5.2331-2340.2003
Functional activity of antibodies against the recombinant OpaJ protein from Neisseria meningitidis
Abstract
The opacity proteins belong to the major outer membrane proteins of the pathogenic Neisseria and are involved in adhesion and invasion. We studied the functional activity of antibodies raised against the OpaJ protein from strain H44/76. Recombinant OpaJ protein was obtained from Escherichia coli in two different ways: cytoplasmic expression in the form of inclusion bodies followed by purification and refolding and cell surface expression followed by isolation of outer membrane complexes (OMCs). Immunization with purified protein and Quillaja saponin A (QuilA) induced high levels of Opa-specific antibodies, whereas the E. coli OMC preparations generally induced lower levels of antibodies. Two chimeric Opa proteins, hybrids between OpaB and OpaJ, were generated to demonstrate that the hypervariable region 2 is immunodominant. Denatured OpaJ with QuilA induced high levels of immunoglobulin G2a (IgG2a) in addition to IgG1, whereas refolded OpaJ with QuilA induced IgG1 exclusively. These sera did not induce significant complement-mediated killing. However, all sera blocked the interaction of OpaJ-expressing bacteria to CEACAM1-transfected cells. In addition, cross-reactive blocking of OpaB-expressing bacteria to both CEACAM1- and CEA-transfected cells was found for all sera. Sera raised against purified OpaJ and against OpaJ-containing meningococcal OMCs also blocked the nonopsonic interaction of Opa-expressing meningococci with human polymorphonuclear leukocytes.
Figures






Similar articles
-
Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins.Vaccine. 2004 Sep 28;22(29-30):4021-8. doi: 10.1016/j.vaccine.2004.03.047. Vaccine. 2004. PMID: 15364452
-
Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles.Vaccine. 2013 Nov 12;31(47):5585-93. doi: 10.1016/j.vaccine.2013.07.069. Epub 2013 Aug 6. Vaccine. 2013. PMID: 23933369
-
Mapping the binding domains on meningococcal Opa proteins for CEACAM1 and CEA receptors.Mol Microbiol. 2003 Nov;50(3):1005-15. doi: 10.1046/j.1365-2958.2003.03749.x. Mol Microbiol. 2003. PMID: 14617157
-
The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.Contrib Microbiol Immunol. 1989;10:151-65. Contrib Microbiol Immunol. 1989. PMID: 2479499 Review. No abstract available.
-
[Active immunization against serogroup B Neisseria meningitidis].Enferm Infecc Microbiol Clin. 2003 Nov;21(9):513-9. doi: 10.1016/s0213-005x(03)72998-x. Enferm Infecc Microbiol Clin. 2003. PMID: 14572386 Review. Spanish.
Cited by
-
Domain exchange at the 3' end of the gene encoding the fratricide meningococcal two-partner secretion protein A.BMC Genomics. 2013 Sep 14;14:622. doi: 10.1186/1471-2164-14-622. BMC Genomics. 2013. PMID: 24034852 Free PMC article.
-
Meningococcal vaccines.Paediatr Drugs. 2004;6(4):251-66. doi: 10.2165/00148581-200406040-00004. Paediatr Drugs. 2004. PMID: 15339202 Review.
-
Phase variation of Opa proteins of Neisseria meningitidis and the effects of bacterial transformation.J Biosci. 2016 Mar;41(1):13-9. doi: 10.1007/s12038-016-9588-y. J Biosci. 2016. PMID: 26949083
-
Neisserial Opa Protein-CEACAM Interactions: Competition for Receptors as a Means of Bacterial Invasion and Pathogenesis.Biochemistry. 2016 Aug 9;55(31):4286-94. doi: 10.1021/acs.biochem.6b00124. Epub 2016 Aug 1. Biochemistry. 2016. PMID: 27442026 Free PMC article.
-
Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.PLoS One. 2012;7(12):e51045. doi: 10.1371/journal.pone.0051045. Epub 2012 Dec 12. PLoS One. 2012. PMID: 23251421 Free PMC article.
References
-
- Abdillahi, H., and J. T. Poolman. 1988. Typing of group B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J. Med. Microbiol. 26:177-180. - PubMed
-
- Agterberg, M., H. Adriaanse, and J. Tommassen. 1987. Use of outer membrane protein PhoE as a carrier for the transport of a foreign antigenic determinant to the cell surface of Escherichia coli K-12. Gene 59:145-150. - PubMed
-
- Bjune, G., E. A. Hoiby, J. K. Gronnesby, O. Arnesen, J. H. Fredriksen, A. Halstensen, E. Holten, A. K. Lindbak, H. Nokleby, E. Rosenqvist, et al. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093-1096. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous